What US FDA’s new surprise foreign inspections plan means for India
Pharma companies exporting to the US should now rightly be on guard and start preparing for the inevitable “knock on the factory…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Express Pharma June 2025
India's Foremost Pharma & Biotech Magazine ~ The Supply Chain Shift: From Pipelines To Lifelines
India’s pharma funding falls by over 90% YoY in April 2025
Total funding drops to $57.7 million across 14 rounds, with early-stage investments comprising over half the capital deployed
Zydus secures tentative USFDA approval for Rifaximin Tablets 550 mg
The tablets, used for treating IBS-D in adults, will be manufactured at the company’s SEZ II facility in Ahmedabad
CAR-T therapies need to overcome current limitations to unlock promising treatment possibilities for…
While CAR-Ts are transforming blood cancer treatment, their struggle in solid tumors highlights the urgent need for innovation in…
Pharma and medtech marketing: Navigating the imminent disclosure deadline
Kunal Gupta, Partner, White-Collar Crime Practice and Sahil Bansal, Counsel - White-Collar Crime Practice, Trilegal stress that…
IDMA appoints Nikkhil K Masurkar as Vice Chairperson of R&D and Innovation Committee
Masurkar has pledged to help mobilise collaborative initiatives that promote research-led development, facilitate strategic…
Sibeprenlimab’s priority review highlights potential to differentiate in IgAN space
Interim results showed that sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour…
7 common compliance issues faced by the pharmaceutical industry in India
Mahesh Krishnamoorthy, Managing Director, Core Integra stresses that compliance in pharma is non-negotiable; highlights seven key…
SeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway
The merger will bring together two business verticals—Global Animal Health and an integrated API business